Successfully Dealing with Business, Regulatory, and Intellectual Property Challenges for Israeli BioMed Companies
June 4, 2007
In cooperation with leading Israeli law office Gross, Kleinhendler, Hodak, Helevy, Greenberg & Co. (GKH), Foley was proud to organize and participate in the conference held in Tel Aviv. The conference addressed challenges faced by Israeli Biomedical companies in successfully dealing with business, regulatory, and intellectual property challenges.
Several Foley attorneys participated in the conference, including:
- Benjamin Berkowitz, associate, Intellectual Property Department
- Lena Robins, senior counsel, Healthcare Industry Team
- David Rosen, co-chair, Life Sciences Industry Team, and lead, FDA Regulatory Practice
- Keith Lindenbaum, partner, Intellectual Property Department
- Richard Peet, partner and chair, International Business Industry Team and Chemical & Pharmaceutical Practice
People
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.